Boston An independent LDT provider

Jeff Borcherding

CEO and President, Immunovia

Jeff became CEO in 2023 after joining Immunovia a year earlier to lead the US organization. Jeff came from Myriad Genetics, where he served as Chief Marketing Officer and General Manager of the Mental Health Diagnostics business. Earlier, he managed healthcare brands at Procter & Gamble. Jeff holds an MBA from the Kellogg School of Management at Northwestern University.